Key Players
- Abbott Laboratories
- Acer Therapeutics
- Aeglea BioTherapeutics
- Arcturus Therapeutics Holdings Inc
- Bausch Health Companies
- Horizon Therapeutics
- Horizon Therapeutics (Ireland)
- Lucane Pharma SA
- Orpharma Pty Ltd
- Recordati Rare Diseases Inc
- Selecta Biosciences
- Ucyclyd Pharma
- Ultragenyx Pharmaceutical Inc
